LU N51 (Abacavir sulfate, lamivudine and zidovudine 300 mg (base) / 150 mg / 300 mg)

Pill imprint LU N51 has been identified as Abacavir sulfate, lamivudine and zidovudine 300 mg (base) / 150 mg / 300 mg.

Abacavir/lamivudine/zidovudine is used in the treatment of hiv infection; occupational exposure; nonoccupational exposure and belongs to the drug class antiviral combinations. Risk cannot be ruled out during pregnancy. Abacavir/lamivudine/zidovudine 300 mg (base) / 150 mg / 300 mg is not a controlled substance under the Controlled Substance Act (CSA).

Abacavir sulfate, lamivudine and zidovudine

Imprint:

LU N51

Strength:

300 mg (base) / 150 mg / 300 mg

Color:

Green

Shape:

Elliptical / Oval

Availability:

Prescription only

Drug Class:

Antiviral combinations

Pregnancy Category:

C - Risk cannot be ruled out

CSA Schedule:

Not a controlled drug

Manufacturer:

Lupin Pharmaceuticals, Inc.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.